Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

107 recalls · Class III, newest first

Class III · Low risk

Avicel

Out of specification results for conductivity.

Terminated Failed specification DuPont Nutrition USA, Inc D-0728-2021
Class III · Low risk

Lidocaine Ointment USP

Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.

Terminated Failed specification Teligent Pharma, Inc. NDC 52565-008-14 D-0785-2021
Class III · Low risk

LEUKINE (Sargramostim)

FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.

Terminated Stability / shelf life Partner Therapeutics Inc NDC 71837-5843-5 D-0655-2021
Class III · Low risk

Phytonadione Tablets 5 mg

Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.

Terminated Impurity / degradation AVKARE Inc. NDC 50268-661-13 D-0631-2021
Class III · Low risk

Atorvastatin Calcium Tablets

Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-121-05 D-0629-2021
Class III · Low risk

Levetiracetam Tablets USP

Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

Terminated Labeling / mix-up McKesson Corporation dba McKesson Drug Company NDC 63739-795-10 D-0630-2021
Class III · Low risk

Readyprep Chg

Superpotent Drug: Product is above specification for active ingredient, 2% Chlorhexidine Gluconate.

Terminated Wrong potency / content Medline Industries Inc D-0624-2021
Class III · Low risk

Atorvastatin Calcium Tablets

Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-121-05 D-0599-2021
Class III · Low risk

Thiamine HCl Injection

Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.

Terminated Labeling / mix-up Mylan Institutional LLC D-0601-2021

Recalls by year